Search research articles
Contact Us
Filters
Showing results (61-70 of 81) with videos related to
Page
of 9
Sort By:
Cancer Research
|
April 17, 2008
Novel and highly recurrent chromosomal alterations in Sézary syndrome
Maarten H Vermeer, Remco van Doorn, Remco Dijkman, et al.
The Journal of Investigative Dermatology
|
June 8, 2007
Multiple self-healing squamous epithelioma in different ethnic groups: more than a founder mutation disorder?
Mariella D'Alessandro, Stephanie E Coats, Susan M Morley, et al.
Cancers
|
October 16, 2024
Chondroitin Sulfate Proteoglycan 4 (CSPG4) as an Emerging Target for Immunotherapy to Treat Melanoma
Xinyi Chen, Shabana Habib, Madalina Alexandru, et al.
Journal of the American Academy of Dermatology
|
November 29, 2005
Defining early mycosis fungoides
Nicola Pimpinelli, Elise A Olsen, Marco Santucci, et al.
Blood
|
February 5, 2005
WHO-EORTC classification for cutaneous lymphomas
Rein Willemze, Elaine S Jaffe, Günter Burg, et al.
Blood
|
August 16, 2011
EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma
Werner Kempf, Katrin Pfaltz, Maarten H Vermeer, et al.
Histopathology
|
January 21, 2014
Aggressive epidermotropic cutaneous CD8+ lymphoma: a cutaneous lymphoma with distinct clinical and pathological features. Report of an EORTC Cutaneous Lymphoma Task Force Workshop
Alistair Robson, Chalid Assaf, Martine Bagot, et al.
Nature Genetics
|
March 2, 2011
Multiple self-healing squamous epithelioma is caused by a disease-specific spectrum of mutations in TGFBR1
David R Goudie, Mariella D'Alessandro, Barry Merriman, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 27, 2023
EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2023
Johanna Latzka, Chalid Assaf, Martine Bagot, et al.
Blood Advances
|
September 10, 2021
Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician's choice in cutaneous T-cell lymphoma: final data
Steven M Horwitz, Julia J Scarisbrick, Reinhard Dummer, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 81) with videos related to
Sort By:
Page
of 9
Cancer Research
|
April 17, 2008
Novel and highly recurrent chromosomal alterations in Sézary syndrome
Maarten H Vermeer, Remco van Doorn, Remco Dijkman, et al.
The Journal of Investigative Dermatology
|
June 8, 2007
Multiple self-healing squamous epithelioma in different ethnic groups: more than a founder mutation disorder?
Mariella D'Alessandro, Stephanie E Coats, Susan M Morley, et al.
Cancers
|
October 16, 2024
Chondroitin Sulfate Proteoglycan 4 (CSPG4) as an Emerging Target for Immunotherapy to Treat Melanoma
Xinyi Chen, Shabana Habib, Madalina Alexandru, et al.
Journal of the American Academy of Dermatology
|
November 29, 2005
Defining early mycosis fungoides
Nicola Pimpinelli, Elise A Olsen, Marco Santucci, et al.
Blood
|
February 5, 2005
WHO-EORTC classification for cutaneous lymphomas
Rein Willemze, Elaine S Jaffe, Günter Burg, et al.
Blood
|
August 16, 2011
EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma
Werner Kempf, Katrin Pfaltz, Maarten H Vermeer, et al.
Histopathology
|
January 21, 2014
Aggressive epidermotropic cutaneous CD8+ lymphoma: a cutaneous lymphoma with distinct clinical and pathological features. Report of an EORTC Cutaneous Lymphoma Task Force Workshop
Alistair Robson, Chalid Assaf, Martine Bagot, et al.
Nature Genetics
|
March 2, 2011
Multiple self-healing squamous epithelioma is caused by a disease-specific spectrum of mutations in TGFBR1
David R Goudie, Mariella D'Alessandro, Barry Merriman, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 27, 2023
EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2023
Johanna Latzka, Chalid Assaf, Martine Bagot, et al.
Blood Advances
|
September 10, 2021
Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician's choice in cutaneous T-cell lymphoma: final data
Steven M Horwitz, Julia J Scarisbrick, Reinhard Dummer, et al.
Page
of 9